Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2015035186) NANOPARTICLE PHORESIS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2015/035186 International Application No.: PCT/US2014/054321
Publication Date: 12.03.2015 International Filing Date: 05.09.2014
IPC:
A61N 2/02 (2006.01) ,A61N 2/10 (2006.01) ,A61B 5/145 (2006.01) ,G06Q 50/22 (2012.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
N
ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
2
Magnetotherapy
02
using magnetic fields produced by coils, including single turn loops or electromagnets
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
N
ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
2
Magnetotherapy
06
using magnetic fields produced by permanent magnets
10
applied within the body, e.g. with injected or implanted elements
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
B
DIAGNOSIS; SURGERY; IDENTIFICATION
5
Measuring for diagnostic purposes; Identification of persons
145
Measuring characteristics of blood in vivo, e.g. gas concentration, pH-value
G PHYSICS
06
COMPUTING; CALCULATING; COUNTING
Q
DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
50
Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
10
Services
22
Health care, e.g. hospitals; Social work
Applicants:
GOOGLE INC. [US/US]; 1600 Amphitheatre Parkway Mountain View, CA 94043, US
Inventors:
CONRAD, Andrew, Jason; US
Agent:
MACHONKIN, Richard, A.; US
Priority Data:
14/018,59105.09.2013US
Title (EN) NANOPARTICLE PHORESIS
(FR) PHORÈSE NANOPARTICULAIRE
Abstract:
(EN) Functionalized particles in the blood are able to selectively bind to targets in the blood that have adverse health effects. The binding of the particles to the targets allows the targets to be selectively modified or destroyed by energy from outside the body such that the adverse health effects are reduced or eliminated. The energy is generated by a wearable device which is able to direct the energy into the subsurface vasculature of the wearer of the wearable device. Further, one or more of the functionalized particles may be magnetic, allowing a magnetic field generated by the wearable device and directed into the subsurface vasculature to concentrate the bound targets in a lumen of the subsurface vasculature proximate to the wearable device.
(FR) L'invention concerne des particules fonctionnalisées dans le sang qui sont capables de se lier sélectivement à des cibles dans le sang qui ont des effets indésirables sur la santé. La liaison des nanoparticules aux cibles permet de modifier ou de détruire sélectivement les cibles par de l'énergie provenant de l'extérieur du corps de telle sorte que les effets indésirables sur la santé sont réduits ou éliminés. L'énergie est produite par un dispositif portable qui est capable de diriger l'énergie dans le système vasculaire subsurfacique du porteur du dispositif portable. En outre, une ou plusieurs particules fonctionnalisées peuvent être magnétiques, ce qui permet à un champ magnétique produit par le dispositif portable et dirigé dans le système vasculaire subsurfacique de concentrer les cibles liées dans une lumière du système vasculaire subsurfacique à proximité du dispositif portable.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)